Table I.
General characteristics of the population and clinical data of patients with childhood acute lymphoblastic leukemia (ALL) and healthy individuals.
| Variable | Patients with ALL (n=70) | Healthy individuals (n=100) |
|---|---|---|
| Age (years; mean ± SD) | 7.65±4.67 | 9.99±5.49 |
| No. of leukocytes/mm3 | 13,000 (5,400–39,000)a | 8,000 (7,000–9,000)a |
| Gender | ||
| Male | 45 (64.29) | 53 (53.00) |
| Female | 25 (35.71) | 47 (47.00) |
| Status of participants | ||
| Alive | 30 (42.86) | 100 (100) |
| Deceased | 40 (57.14) | 0 |
| Immunophenotype | ||
| B-lineage | 66 (94.28) | 0 |
| T-lineage | 4 (5.72) | 0 |
| Risk by age | ||
| Standard (1–9 years) | 18 (25.71) | 0 |
| High (<1 and >9 years) | 52 (74.29) | 0 |
| Relapse during treatment | ||
| No | 22 (31.43) | 0 |
| Yes | 48 (68.57) | 0 |
Data indicate n (%);
a
median (percentiles 25–75).